Cancer Clinical Trials: What the Public Health and Primary Care Provider Need to Know
Presenters:
Yelena Novik, MD, FACP, Assistant Professor; Medical Director-Clinical Trials Office, NYU Clinical Cancer Center, Department of Medicine (Residency Program), NYU Medical Oncology Associates
Michael L. Pearl, MD, FACOG, FACS, Professor and Director, Division of Gynecological Oncology, Stony Brook University Hospital
At the conclusion of the presentation, the participants will be able to:
List basic principles relating to cancer clinical trials, including purpose/limitations of Phase I, II and III clinical trials.
Describe the benefits associated with cancer clinical trials, using lessons learned and best practices gleaned from pediatric cancer clinical trials as a model.
Recognize barriers to participation in clinical trials among adults at-risk for or affected with cancer and identify disparities in clinical trial participation.